Has Abraham Areephanthu, MD received payments from drug or device companies?

Yes. Drug and device makers reported $21,790 in general payments to Abraham Areephanthu, MD across 1,450 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Abraham Areephanthu, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Abraham Areephanthu, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Abraham Areephanthu, MD

Family Medicine · Hartsville, SCNPI 1548235757

Payments from drug & device makers

$21,790in general payments, 2019–2025

Across 1,450 payments — averaging $15.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$3K
AstraZeneca$2K
Lilly USA, LLC$2K
Pfizer$1K
Novo Nordisk$1K
Boehringer Ingelheim$1K
plus $12K from 54 others

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie(2 entities)	230	$2,956
AstraZeneca(2 entities)	98	$1,916
Lilly USA, LLC	142	$1,524
Pfizer	94	$1,388
Novo Nordisk	90	$1,234
Boehringer Ingelheim	72	$1,010
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	54	$827
GSK	57	$774
Ironwood Pharmaceuticals, Inc	48	$753
Takeda Pharmaceuticals U.S.A., Inc.	44	$716
Amgen(2 entities)	38	$657
Bayer	45	$549
Johnson & Johnson	29	$446
Otsuka America Pharmaceutical, Inc.	23	$430
Merck	31	$395
Supernus Pharmaceuticals, Inc.	5	$362
Amarin Pharma, Inc.	19	$342
Novartis	20	$332
Corcept Therapeutics	18	$325
Teva Pharmaceuticals USA, Inc.	28	$314
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	16	$299
Abbott	18	$297
Sunovion Pharmaceuticals Inc.	18	$293
Vanda Pharmaceuticals Inc.	9	$260
Optinose US, Inc.	15	$257
Mylan Specialty L.p.	15	$256
Exact Sciences	15	$230
Biohaven Pharmaceutical Holding Company Ltd.	8	$168
Adlon Therapeutics L.p.	11	$165
Astellas Pharma US Inc	10	$156
Biohaven Pharmaceuticals, Inc.	8	$146
Xeris Pharmaceuticals, Inc.	7	$141
Nestle Healthcare Nutrition Inc.	9	$135
Antares Pharma, Inc.	7	$132
E.r. Squibb & Sons, L.L.C.	8	$108
Insulet Corporation	6	$99
Jazz Pharmaceuticals Inc.	6	$98
Sanofi-aventis U.S. LLC	6	$87
Phathom Pharmaceuticals, Inc.	7	$70
Forte Bio-pharma LLC	2	$68
Eisai Inc.	4	$66
Kowa Pharmaceuticals America, Inc.	5	$64
Lundbeck LLC	3	$62
Tolmar, Inc.	4	$60
Arbor Pharmaceuticals, Inc.	4	$58
Paratek Pharmaceuticals, Inc.	4	$56
Dexcom, Inc.	3	$54
Axsome Therapeutics, Inc.	3	$54
Viatris Specialty LLC	2	$43
Neos Therapeutics, LP	3	$41
Shield Therapeutics Inc	2	$37
Halozyme Inc	2	$36
Acerus Pharmaceuticals Corporation	2	$34
Edwards Lifesciences	2	$34
Tris Pharma Inc	2	$32
Shire North American Group Inc	2	$28
Otsuka Pharmaceutical Development & Commercialization, Inc.	1	$27
Sanofi	1	$25
Aytu Biopharma, Inc.	1	$24
Vapotherm Inc	1	$22

How this compares

$21,790 in reported general payments places this provider in the 95th percentile of 2,153 family medicine providers in South Carolina.

See all family medicine providers in South Carolina →

Medicare billing

Part B allowed, 2024

$250,789

Medicare patients

581

Services billed

6,829

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family medicine in Hartsville

Cayce TangemanGoose Creek$8.4M
Jeremy AckermannMoncks Corner$7.6M
Kelly MoralesNorth Charleston$6.5M
William ByarsGreer$4.8M
James FranklinGreenville$3.5M
Stephen GrubbLittle River$3.4M
Jeffrey HarrisGreenville$3.4M
Shannon ConradN Charleston$3.3M
Tom ChristensenLittle River$3.1M
Edward NewtonCharleston$3M

See the full list for South Carolina →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →